Advertisement
Loading...

111, Inc.

YINASDAQ
Healthcare
Medical - Pharmaceuticals
$5.88
$-0.12(-2.00%)
U.S. Market is Open • 11:55

111, Inc. Fundamental Analysis

111, Inc. (YI) shows weak financial fundamentals with a PE ratio of -6.24, profit margin of -0.45%, and ROE of 8.26%. The company generates $12.4B in annual revenue with weak year-over-year growth of -3.66%.

Key Strengths

Cash Position1203.64%
PEG Ratio0.35

Areas of Concern

ROE8.26%
Operating Margin-0.05%
We analyze YI's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 30.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
30.6/100

We analyze YI's fundamental strength across five key dimensions:

Efficiency Score

Weak

YI struggles to generate sufficient returns from assets.

ROA > 10%
-2.55%

Valuation Score

Excellent

YI trades at attractive valuation levels.

PE < 25
-6.24
PEG Ratio < 2
0.35

Growth Score

Moderate

YI shows steady but slowing expansion.

Revenue Growth > 5%
-3.66%
EPS Growth > 10%
83.86%

Financial Health Score

Excellent

YI maintains a strong and stable balance sheet.

Debt/Equity < 1
-0.31
Current Ratio > 1
1.09

Profitability Score

Weak

YI struggles to sustain strong margins.

ROE > 15%
8.26%
Net Margin ≥ 15%
-0.45%
Positive Free Cash Flow
No

Key Financial Metrics

Is YI Expensive or Cheap?

P/E Ratio

YI trades at -6.24 times earnings. This suggests potential undervaluation.

-6.24

PEG Ratio

When adjusting for growth, YI's PEG of 0.35 indicates potential undervaluation.

0.35

Price to Book

The market values 111, Inc. at -0.50 times its book value. This may indicate undervaluation.

-0.50

EV/EBITDA

Enterprise value stands at 192.68 times EBITDA. This signals the market has high growth expectations.

192.68

How Well Does YI Make Money?

Net Profit Margin

For every $100 in sales, 111, Inc. keeps $-0.45 as profit after all expenses.

-0.45%

Operating Margin

Core operations generate -0.05 in profit for every $100 in revenue, before interest and taxes.

-0.05%

ROE

Management delivers $8.26 in profit for every $100 of shareholder equity.

8.26%

ROA

111, Inc. generates $-2.55 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.55%

Following the Money - Real Cash Generation

Operating Cash Flow

111, Inc. generates limited operating cash flow of $2.62M, signaling weaker underlying cash strength.

$2.62M

Free Cash Flow

111, Inc. generates weak or negative free cash flow of $-12.47M, restricting financial flexibility.

$-12.47M

FCF Per Share

Each share generates $-1.43 in free cash annually.

$-1.43

FCF Yield

YI converts -3.62% of its market value into free cash.

-3.62%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-6.24

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.35

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.50

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.03

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.31

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.09

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.08

vs 25 benchmark

ROA

Return on assets percentage

-0.03

vs 25 benchmark

ROCE

Return on capital employed

-0.03

vs 25 benchmark

How YI Stacks Against Its Sector Peers

MetricYI ValueSector AveragePerformance
P/E Ratio-6.2428.62 Better (Cheaper)
ROE8.26%788.00% Weak
Net Margin-0.45%-48085.00% (disorted) Weak
Debt/Equity-0.310.39 Strong (Low Leverage)
Current Ratio1.094.11 Neutral
ROA-2.55%-21875.00% (disorted) Weak

YI outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews 111, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

246.05%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

87.75%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

148.96%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ